Identifying Potentially Preventable Death From Sepsis
Recommended Citation
Munroe E, Basu T, O'Malley ME, McLaughlin E, Horowitz JK, Posa P, Jayaprakash N, Blamoun J, Flanders SA, Angus DC, Prescott HC. Identifying Potentially Preventable Death From Sepsis. Am J Respir Crit Care Med 2023; 207(1).
Document Type
Conference Proceeding
Publication Date
4-20-2023
Publication Title
Am J Respir Crit Care Med
Abstract
Rationale: Sepsis is a major cause of hospital mortality, contributing to 1 out of every 2-3 US hospital deaths. However, it is unclear how often sepsis deaths are preventable, as patients hospitalized with sepsis are often elderly, frail, or have multimorbidity. We sought to identify a cohort of previously healthy patients hospitalized for sepsis to assess for potentially preventable sepsis deaths. Methods: This cohort study included adults hospitalized with community-onset sepsis at 13 hospitals in the Michigan Hospital Medicine Safety Consortium (HMS), a Collaborative Quality Initiative within Blue Cross Blue Shield of Michigan Value Partnership Program. Hospitalization data were abstracted into the HMS-Sepsis registry (11/2020-2/2022) by professional abstractors. All patients met CDC sepsis surveillance criteria. Using this registry, we serially excluded older, frail, multimorbid patients to enrich for a “healthy sepsis” sub-cohort while retaining ≥10% of hospitalizations. Results: Of 3,053 patients in the HMS-Sepsis registry, 840 (27.5%) died within 90 days. A majority (1,949, 63.8%) were ≥70 years old, had baseline cognitive or functional impairments, or had cancer. After excluding these patients (Figure 1), 90-day mortality decreased to 15.2%. After applying all 16 exclusions (Figure 1), the final healthy sepsis cohort included 369 (12.1%) patients, with 90-day mortality of 10.0%. All healthy sepsis patients had acute organ dysfunction on presentation, most commonly respiratory dysfunction (82.4% on ≥4L NC), lactate elevation (27.4%), altered mental status (12.7%), and shock (8.8%). Only 1.4% had treatment limitations on admission vs 19.0% in the comorbid sepsis cohort, p<0.001. Compared to healthy sepsis patients who survived, healthy sepsis patients who died were more often admitted directly to the ICU (81.1% vs 20.2%, p<0.001) and had worse organ dysfunction on presentation (median PaO2:FiO2 110 vs 217, p<0.001; median lactate 2.9 vs 2.2 mmol/L, p=0.03; mental status alteration 27.9% vs 11.1%, p=0.006; shock 21.6% vs 7.5%, p=0.01). Compared to comorbid sepsis deaths, healthy sepsis deaths occurred later (86.5% after day 7) and in-hospital (70.3%; median length of stay 15 days). Healthy sepsis mortality varied by hospital, with a pooled 90-day mortality of 3.5% in the highest-performing tercile of hospitals (encompassing 116/369 healthy sepsis hospitalizations) vs 16.5% in the lowest tercile. Conclusions: After excluding older, multimorbid patients, the resulting healthy sepsis cohort had substantially lower mortality, particularly at top-performing hospitals. Acute respiratory failure was the most common organ dysfunction, and deaths generally occurred beyond day 7 after long hospital courses, providing potential targets for preventing sepsis deaths.
Volume
207
Issue
1
